{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:52:01Z","timestamp":1792547521488,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["17127417"],"award-info":[{"award-number":["17127417"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41380-024-02723-1","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T20:21:38Z","timestamp":1725308498000},"page":"954-967","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Adverse obstetric and neonatal outcomes associated with maternal schizophrenia-spectrum disorders and prenatal antipsychotic use: a meta-analysis of 37,214,330 pregnancy deliveries and propensity-score weighted population-based cohort study assessing confounder dependency of risk estimates"],"prefix":"10.1038","volume":"30","author":[{"given":"Joe Kwun Nam","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal Chi Kei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-5646","authenticated-orcid":false,"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuen Kiu","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Yui","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3363-1004","authenticated-orcid":false,"given":"Corine Sau Man","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Wang","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi Tin-Yan","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3581-8895","authenticated-orcid":false,"given":"Wing Chung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"2723_CR1","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/schbul\/sbx056","volume":"43","author":"WC Chang","year":"2017","unstructured":"Chang WC, Wong CSM, Chen EYH, Lam LCW, Chan WC, Ng RMK, et al. Lifetime prevalence and correlates of schizophrenia-spectrum, affective, and other non-affective psychotic disorders in the Chinese adult population. Schizophr Bull. 2017;43:1280\u201310.","journal-title":"Schizophr Bull"},{"key":"2723_CR2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","volume":"399","author":"S Jauhar","year":"2022","unstructured":"Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399:473\u201386.","journal-title":"Lancet"},{"key":"2723_CR3","doi-asserted-by":"publisher","unstructured":"Solmi M, Seitidis G, Mavridis D, Correll CU, Dragioti E, Guimond S, et al. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019. Mol Psychiatry. 2023. https:\/\/doi.org\/10.1038\/s41380-023-02138-4","DOI":"10.1038\/s41380-023-02138-4"},{"key":"2723_CR4","doi-asserted-by":"crossref","first-page":"102294","DOI":"10.1016\/j.eclinm.2023.102294","volume":"65","author":"JKN Chan","year":"2023","unstructured":"Chan JKN, Correll CU, Wong CSM, Chu RST, Fung VSC, Wong GHS, et al. Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis. eClinicalMedicine. 2023;65:102294.","journal-title":"eClinicalMedicine"},{"key":"2723_CR5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/wps.20420","volume":"16","author":"CU Correll","year":"2017","unstructured":"Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16:163\u201380.","journal-title":"World Psychiatry"},{"key":"2723_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/wps.20994","volume":"21","author":"CU Correll","year":"2022","unstructured":"Correll CU, Solmi M, Croatto G, Schneider LK, Rohani-Montez SC, Fairley L, et al. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry. 2022;21:248\u201371.","journal-title":"World Psychiatry"},{"key":"2723_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27:281\u201395.","journal-title":"Mol Psychiatry"},{"key":"2723_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2020.03.037","volume":"269","author":"H Hope","year":"2020","unstructured":"Hope H, Parisi R, Ashcroft DM, Williams R, Coton S, Kosidou K, et al. Fertility trends of women with serious mental illness in the United Kingdom 1992-2017: a primary care cohort study using the clinical practice research datalink. J Affect Disord. 2020;269:141\u20137.","journal-title":"J Affect Disord"},{"key":"2723_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2012.05.010","volume":"139","author":"SN Vigod","year":"2012","unstructured":"Vigod SN, Seeman MV, Ray JG, Anderson GM, Dennis CL, Grigoriadis S, et al. Temporal trends in general and age-specific fertility rates among women with schizophrenia (1996-2009): a population-based study in Ontario, Canada. Schizophr Res. 2012;139:169\u201375.","journal-title":"Schizophr Res"},{"key":"2723_CR10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YCO.0000000000000706","volume":"34","author":"P Dazzan","year":"2021","unstructured":"Dazzan P. Schizophrenia during pregnancy. Curr Opin Psychiatry. 2021;34:238\u201344.","journal-title":"Curr Opin Psychiatry"},{"key":"2723_CR11","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1192\/bjo.2020.78","volume":"6","author":"CL Taylor","year":"2020","unstructured":"Taylor CL, Munk-Olsen T, Howard LM, Vigod SN. Schizophrenia around the time of pregnancy: leveraging population-based health data and electronic health record data to fill knowledge gaps. BJPsych Open. 2020;6:e97.","journal-title":"BJPsych Open"},{"key":"2723_CR12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S003329170003467X","volume":"26","author":"A Sacker","year":"1996","unstructured":"Sacker A, Done DJ, Crow TJ. Obstetric complications in children born to parents with schizophrenia: a meta-analysis of case-control studies. Psychol Med. 1996;26:279\u201387.","journal-title":"Psychol Med"},{"key":"2723_CR13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1176\/appi.ajp.162.6.1045","volume":"162","author":"R Webb","year":"2005","unstructured":"Webb R, Abel K, Pickles A, Appleby L. Mortality in offspring of parents with psychotic disorders: a critical review and meta-analysis. Am J Psychiatry. 2005;162:1045\u201356.","journal-title":"Am J Psychiatry"},{"key":"2723_CR14","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.4088\/JCP.15r10483","volume":"78","author":"S Tosato","year":"2017","unstructured":"Tosato S, Albert U, Tomassi S, Iasevoli F, Carmassi C, Ferrari S, et al. A systematized review of atypical antipsychotics in pregnant women: balancing between risks of untreated illness and risks of drug-related adverse effects. J Clin Psychiatry. 2017;78:e477\u201389.","journal-title":"J Clin Psychiatry"},{"key":"2723_CR15","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41380-022-01593-9","volume":"27","author":"D Etchecopar-Etchart","year":"2022","unstructured":"Etchecopar-Etchart D, Mignon R, Boyer L, Fond G. Schizophrenia pregnancies should be given greater health priority in the global health agenda: results from a large-scale meta-analysis of 43,611 deliveries of women with schizophrenia and 40,948,272 controls. Mol Psychiatry. 2022;27:3294\u2013305.","journal-title":"Mol Psychiatry"},{"key":"2723_CR16","doi-asserted-by":"crossref","first-page":"519.e1","DOI":"10.1016\/j.ajog.2016.06.017","volume":"215","author":"RJ Baer","year":"2016","unstructured":"Baer RJ, Chambers CD, Bandoli G, Jelliffe-Pawlowski LL. Risk of preterm birth by subtype among Medi-Cal participants with mental illness. Am J Obstet Gynecol. 2016;215:519.e1\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"2723_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0029-1225529","volume":"27","author":"R Hizkiyahu","year":"2010","unstructured":"Hizkiyahu R, Levy A, Sheiner E. Pregnancy outcome of patients with schizophrenia. Am J Perinatol. 2010;27:19\u201323.","journal-title":"Am J Perinatol"},{"key":"2723_CR18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/appi.ajp.162.1.79","volume":"162","author":"AV Jablensky","year":"2005","unstructured":"Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry. 2005;162:79\u201391.","journal-title":"Am J Psychiatry"},{"key":"2723_CR19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jad.2009.05.019","volume":"121","author":"HC Lee","year":"2010","unstructured":"Lee HC, Lin HC. Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study. J Affect Disord. 2010;121:100\u20135.","journal-title":"J Affect Disord"},{"key":"2723_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.annepidem.2015.09.009","volume":"26","author":"T M\u00e4nnist\u00f6","year":"2016","unstructured":"M\u00e4nnist\u00f6 T, Mendola P, Kiely M, O\u2019Loughlin J, Werder E, Chen Z, et al. Maternal psychiatric disorders and risk of preterm birth. Ann Epidemiol. 2016;26:14\u201320.","journal-title":"Ann Epidemiol"},{"key":"2723_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1192\/bjp.175.3.239","volume":"175","author":"BE Bennedsen","year":"1999","unstructured":"Bennedsen BE, Mortensen PB, Olesen AV, Henriksen TB. Preterm birth and intra-uterine growth retardation among children of women with schizophrenia. Br J Psychiatry. 1999;175:239\u201345.","journal-title":"Br J Psychiatry"},{"key":"2723_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0920-9964(99)00234-0","volume":"47","author":"BE Bennedsen","year":"2001","unstructured":"Bennedsen BE, Mortensen PB, Olesen AV, Henriksen TB, Frydenberg M. Obstetric complications in women with schizophrenia. Schizophr Res. 2001;47:167\u201375.","journal-title":"Schizophr Res"},{"key":"2723_CR23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0920-9964(01)00370-X","volume":"58","author":"E Nilsson","year":"2002","unstructured":"Nilsson E, Lichtenstein P, Cnattingius S, Murray RM, Hultman CM. Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res. 2002;58:221\u20139.","journal-title":"Schizophr Res"},{"key":"2723_CR24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1192\/bjp.bp.107.045146","volume":"193","author":"E Nilsson","year":"2008","unstructured":"Nilsson E, Hultman CM, Cnattingius S, Olausson PO, Bj\u00f6rk C, Lichtenstein P. Schizophrenia and offspring\u2019s risk for adverse pregnancy outcomes and infant death. Br J Psychiatry. 2008;193:311\u20135.","journal-title":"Br J Psychiatry"},{"key":"2723_CR25","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/1471-0528.12567","volume":"121","author":"SN Vigod","year":"2014","unstructured":"Vigod SN, Kurdyak PA, Dennis CL, Gruneir A, Newman A, Seeman MV, et al. Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study. BJOG. 2014;121:566\u201374.","journal-title":"BJOG"},{"key":"2723_CR26","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1176\/ajp.2006.163.12.2170","volume":"163","author":"RT Webb","year":"2006","unstructured":"Webb RT, Abel KM, Pickles AR, Appleby L, King-Hele SA, Mortensen PB. Mortality risk among offspring of psychiatric inpatients: a population-based follow-up to early adulthood. Am J Psychiatry. 2006;163:2170\u20137.","journal-title":"Am J Psychiatry"},{"key":"2723_CR27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00737-019-0948-0","volume":"23","author":"L Simoila","year":"2020","unstructured":"Simoila L, Isomets\u00e4 E, Gissler M, Suvisaari J, Halmesm\u00e4ki E, Lindberg N. Schizophrenia and pregnancy: a national register-based follow-up study among Finnish women born between 1965 and 1980. Arch Womens Ment Health. 2020;23:91\u2013100.","journal-title":"Arch Womens Ment Health"},{"key":"2723_CR28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00127-019-01814-7","volume":"55","author":"SN Vigod","year":"2020","unstructured":"Vigod SN, Fung K, Amartey A, Bartsch E, Felemban R, Saunders N, et al. Maternal schizophrenia and adverse birth outcomes: what mediates the risk? Soc Psychiatry Psychiatr Epidemiol. 2020;55:561\u201370.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2723_CR29","doi-asserted-by":"crossref","first-page":"e1004256","DOI":"10.1371\/journal.pmed.1004256","volume":"20","author":"W Yin","year":"2023","unstructured":"Yin W, Ludvigsson JF, \u00c5den U, Risnes K, Persson M, Reichenberg A, et al. Paternal and maternal psychiatric history and risk of preterm and early term birth: a nationwide study using Swedish registers. PLoS Med. 2023;20:e1004256.","journal-title":"PLoS Med"},{"key":"2723_CR30","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-018-1750-0","volume":"18","author":"QY Zhong","year":"2018","unstructured":"Zhong QY, Gelaye B, Fricchione GL, Avillach P, Karlson EW, Williams MA. Adverse obstetric and neonatal outcomes complicated by psychosis among pregnant women in the United States. BMC Pregnancy Childbirth. 2018;18:120.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2723_CR31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41372-019-0346-5","volume":"39","author":"H Heun-Johnson","year":"2019","unstructured":"Heun-Johnson H, Seabury SA, Menchine M, Claudius I, Axeen S, Lakshmanan A. Association between maternal serious mental illness and adverse birth outcomes. J Perinatol. 2019;39:737\u201345.","journal-title":"J Perinatol"},{"key":"2723_CR32","volume":"1","author":"RS Kahn","year":"2015","unstructured":"Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, et al. Schizophrenia. Nat Rev Dis Primers. 2015;1:15067.","journal-title":"Nat Rev Dis Primers"},{"key":"2723_CR33","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1017\/S003329171900401X","volume":"51","author":"Z Wang","year":"2021","unstructured":"Wang Z, Wong ICK, Man KKC, Alfageh BH, Mongkhon P, Brauer R. The use of antipsychotic agents during pregnancy and the risk of gestational diabetes mellitus: a systematic review and meta-analysis. Psychol Med. 2021;51:1028\u201337.","journal-title":"Psychol Med"},{"key":"2723_CR34","doi-asserted-by":"crossref","first-page":"h2298","DOI":"10.1136\/bmj.h2298","volume":"350","author":"SN Vigod","year":"2015","unstructured":"Vigod SN, Gomes T, Wilton AS, Taylor VH, Ray JG. Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ. 2015;350:h2298.","journal-title":"BMJ"},{"key":"2723_CR35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2009.10.011","volume":"116","author":"HC Lin","year":"2010","unstructured":"Lin HC, Chen IJ, Chen YH, Lee HC, Wu FJ. Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res. 2010;116:55\u201360.","journal-title":"Schizophr Res"},{"key":"2723_CR36","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008\u201312.","journal-title":"JAMA"},{"key":"2723_CR37","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"2723_CR38","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2009. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"2723_CR39","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF. What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690\u20131.","journal-title":"JAMA"},{"key":"2723_CR40","unstructured":"Hospital Authority Head Office IT Department. Clinical Data Analysis & Reporting System (CDARS) User\u2019s Manual: 2.0 ed. Hong Kong: Hong Kong Hospital Authority; 2003."},{"key":"2723_CR41","first-page":"307","volume":"129","author":"NT Cheung","year":"2007","unstructured":"Cheung NT, Fung V, Wong WN, Tong A, Sek A, Greyling A, et al. Principles-based medical informatics for success - how Hong Kong built one of the world\u2019s largest integrated longitudinal electronic patient records. Stud Health Technol Inform. 2007;129:307\u201310.","journal-title":"Stud Health Technol Inform"},{"key":"2723_CR42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1192\/bjp.2020.248","volume":"219","author":"JKN Chan","year":"2021","unstructured":"Chan JKN, Wong CSM, Or PCF, Chen EYH, Chang WC. Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study. Br J Psychiatry. 2021;219:375\u201382.","journal-title":"Br J Psychiatry"},{"key":"2723_CR43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00127-021-02130-9","volume":"57","author":"JKN Chan","year":"2022","unstructured":"Chan JKN, Wong CSM, Yung NCL, Chen EYH, Chang WC. Pre-existing chronic physical morbidity and excess mortality in people with schizophrenia: a population-based cohort study. Soc Psychiatry Psychiatr Epidemiol. 2022;57:485\u201393.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2723_CR44","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/schbul\/sbaa013","volume":"46","author":"WC Chang","year":"2020","unstructured":"Chang WC, Chan JKN, Wong CSM, Hai JSH, Or PCF, Chen EYH. Mortality, revascularization and cardioprotective pharmacotherapy after acute coronary syndrome in patients with psychotic disorders: a population-based cohort study. Schizophr Bull. 2020;46:774\u201384.","journal-title":"Schizophr Bull"},{"key":"2723_CR45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.euroneuro.2019.12.107","volume":"31","author":"NCL Yung","year":"2020","unstructured":"Yung NCL, Wong CSM, Chan JKN, Or PCF, Chen EYH, Chang WC. Mortality in patients with schizophrenia admitted for incident ischemic stroke: a population-based cohort study. Eur Neuropsychopharm. 2020;31:152\u20137.","journal-title":"Eur Neuropsychopharm"},{"key":"2723_CR46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/schbul\/sbaa137","volume":"47","author":"NCL Yung","year":"2021","unstructured":"Yung NCL, Wong CSM, Chan JKN, Chen EYH, Chang WC. Excess mortality and life-years lost in people with schizophrenia and other non-affective psychoses: an 11-year population-based cohort study. Schizophr Bull. 2021;47:474\u201384.","journal-title":"Schizophr Bull"},{"key":"2723_CR47","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/00048674221109443","volume":"57","author":"C Hung","year":"2023","unstructured":"Hung C, Chan JKN, Wong CSM, Fung VSC, Lee KCK, Chang WC. Antidepressant utilization patterns and predictors of treatment continuation in pregnant women: a 16-year population-based cohort. Aust N Z J Psychiatry. 2023;57:686\u201397.","journal-title":"Aust N Z J Psychiatry"},{"key":"2723_CR48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2022.01.115","volume":"57","author":"ACO Kan","year":"2022","unstructured":"Kan ACO, Chan JKN, Wong CSM, Chen EYH, Chang WC. Psychotropic drug utilization patterns in pregnant women with bipolar disorder: a 16-year population-based cohort study. Eur Neuropsychopharmacol. 2022;57:75\u201385.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2723_CR49","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00406-022-01453-1","volume":"273","author":"JWY Law","year":"2023","unstructured":"Law JWY, Chan JKN, Wong CSM, Chen EYH, Chang WC. Antipsychotic utilization patterns in pregnant women with psychotic disorders: a 16-year population-based cohort study. Eur Arch Psychiatry Clin Neurosci. 2023;273:901\u20139.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2723_CR50","first-page":"j2350","volume":"357","author":"KKC Man","year":"2017","unstructured":"Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, et al. Prenatal antidepressant use and risk of attention-deficit\/hyperactivity disorder in offspring: population based cohort study. BMJ. 2017;357:j2350.","journal-title":"BMJ"},{"key":"2723_CR51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.schres.2009.09.037","volume":"115","author":"WC Chang","year":"2009","unstructured":"Chang WC, Pang SLK, Chung DWS, Chan SSM. Five-year stability of ICD-10 diagnoses among Chinese patients presented with first-episode psychosis in Hong Kong. Schizophr Res. 2009;115:351\u20137.","journal-title":"Schizophr Res"},{"key":"2723_CR52","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613\u20139.","journal-title":"J Clin Epidemiol"},{"key":"2723_CR53","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/sim.5753","volume":"32","author":"DF McCaffrey","year":"2013","unstructured":"McCaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32:3388\u2013414.","journal-title":"Stat Med"},{"key":"2723_CR54","first-page":"15657","volume":"367","author":"RJ Desai","year":"2019","unstructured":"Desai RJ, Franklin JM. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ. 2019;367:15657.","journal-title":"BMJ"},{"key":"2723_CR55","unstructured":"Ridgeway G, McCaffrey D, Morral A, Cefalu M, Burgette L, Pane J, Griffin BA. Toolkit for Weighting and Analysis of Nonequivalent Groups: A guide to the twang package. 2024. https:\/\/cran.r-project.org\/web\/packages\/twang\/vignettes\/twang.pdf."},{"key":"2723_CR56","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/archpsyc.58.7.674","volume":"58","author":"BE Bennedsen","year":"2001","unstructured":"Bennedsen BE, Mortensen PB, Olesen AV, Henriksen TB. Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Arch Gen Psychiatry. 2001;58:674\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"2723_CR57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/070674371005500607","volume":"55","author":"HC Lin","year":"2010","unstructured":"Lin HC, Lee HC, Tang CH, Chen YH. The relation between maternal schizophrenia and low birth weight is modified by paternal age. Can J Psychiatry. 2010;55:377\u201385.","journal-title":"Can J Psychiatry"},{"key":"2723_CR58","volume":"10","author":"C Fabre","year":"2021","unstructured":"Fabre C, Pauly V, Baumstarck K, Etchecopar-Etchart D, Orleans V, Llorca PM, et al. Pregnancy, delivery and neonatal complications in women with schizophrenia: a national population-based cohort study. Lancet Reg Health Eur. 2021;10:100209.","journal-title":"Lancet Reg Health Eur"},{"key":"2723_CR59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eurpsy.2018.04.001","volume":"52","author":"L Simoila","year":"2018","unstructured":"Simoila L, Isomets\u00e4 E, Gissler M, Suvisaari J, Halmesm\u00e4ki E, Lindberg N. Obstetric and perinatal health outcomes related to schizophrenia: a national register-based follow-up study among Finnish women born between 1965 and 1980 and their offspring. Eur Psychiatry. 2018;52:68\u201375.","journal-title":"Eur Psychiatry"},{"key":"2723_CR60","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4088\/JCP.14m09070","volume":"76","author":"AL Sutter-Dallay","year":"2015","unstructured":"Sutter-Dallay AL, Bales M, Pambrun E, Glangeaud-Freudenthal NM, Wisner KL, Verdoux H. Impact of prenatal exposure to psychotropic drugs on neonatal outcome in infants of mothers with serious psychiatric illnesses. J Clin Psychiatry. 2015;76:967\u201373.","journal-title":"J Clin Psychiatry"},{"key":"2723_CR61","doi-asserted-by":"crossref","first-page":"e94788","DOI":"10.1371\/journal.pone.0094788","volume":"9","author":"J Kulkarni","year":"2014","unstructured":"Kulkarni J, Worsley R, Gilbert H, Gavrilidis E, Van Rheenen TE, Wang W, et al. A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies. PLoS ONE. 2014;9:e94788.","journal-title":"PLoS ONE"},{"key":"2723_CR62","doi-asserted-by":"crossref","first-page":"e061328","DOI":"10.1136\/bmjopen-2022-061328","volume":"12","author":"E Heinonen","year":"2022","unstructured":"Heinonen E, Forsberg L, N\u00f6rby U, Wide K, K\u00e4ll\u00e9n K. Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study. BMJ Open. 2022;12:e061328.","journal-title":"BMJ Open"},{"key":"2723_CR63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00228-019-02769-z","volume":"76","author":"M Ellfolk","year":"2020","unstructured":"Ellfolk M, Leinonen MK, Gissler M, Lahesmaa-Korpinen AM, Saastamoinen L, Nurminen ML, et al. Second-generation antipsychotics and pregnancy complications. Eur J Clin Pharmacol. 2020;76:107\u201315.","journal-title":"Eur J Clin Pharmacol"},{"key":"2723_CR64","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40263-022-00908-2","volume":"36","author":"E Heinonen","year":"2022","unstructured":"Heinonen E, Forsberg L, N\u00f6rby U, Wide K, K\u00e4ll\u00e9n K. Antipsychotic use during pregnancy and risk for gestational diabetes: a national register-based cohort study in Sweden. CNS Drugs. 2022;36:529\u201339.","journal-title":"CNS Drugs"},{"key":"2723_CR65","volume":"15","author":"CL Taylor","year":"2015","unstructured":"Taylor CL, Stewart R, Ogden J, Broadbent M, Pasupathy D, Howard LM. The characteristics and health needs of pregnant women with schizophrenia compared with bipolar disorder and affective psychoses. BMC Psychiatry. 2015;15:88.","journal-title":"BMC Psychiatry"},{"key":"2723_CR66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpsychires.2018.06.019","volume":"104","author":"CL Taylor","year":"2018","unstructured":"Taylor CL, Broadbent M, Khondoker M, Stewart RJ, Howard LM. Predictors of severe relapse in pregnant women with psychotic or bipolar disorders. J Psychiatr Res. 2018;104:100\u20137.","journal-title":"J Psychiatr Res"},{"key":"2723_CR67","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/wps.20769","volume":"19","author":"LM Howard","year":"2020","unstructured":"Howard LM, Khalifeh H. Perinatal mental health: a review of progress and challenges. World Psychiatry. 2020;19:313\u201327.","journal-title":"World Psychiatry"},{"key":"2723_CR68","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1080\/14656566.2019.1612876","volume":"20","author":"C Breadon","year":"2019","unstructured":"Breadon C, Kulkarni J. An update on medication management of women with schizophrenia in pregnancy. Expert Opin Pharmacother. 2019;20:1365\u201376.","journal-title":"Expert Opin Pharmacother"},{"key":"2723_CR69","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-016-0963-x","volume":"16","author":"KA Davis","year":"2016","unstructured":"Davis KA, Sudlow CL, Hotopf M. Can mental health diagnoses in administrative data be used for research? A systematic review of the accuracy of routinely collected diagnoses. BMC Psychiatry. 2016;16:263.","journal-title":"BMC Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02723-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02723-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02723-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T14:40:42Z","timestamp":1739889642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02723-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2723"],"URL":"https:\/\/doi.org\/10.1038\/s41380-024-02723-1","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"16 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CUC has been a consultant and\/or advisor to or has received honoraria from: AbbVie, Acadia, Adock Ingram, Alkermes, Allergan, Angelini, Aristo, Biogen, Boehringer-Ingelheim, Bristol-Meyers Squibb, Car dio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Delpor, Denovo, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Jamjoom Pharma, Janssen\/J&J, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Merck, Mindpax, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Neurelis, Newron, Noven, Novo Nordisk, Otsuka, Pharmabrain, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Sage, Seqirus, SK Life Science, Sumitomo Pharma America, Sunovion, Sun Pharma, Supernus, Tabuk, Takeda, Teva, Tolmar, Vertex, and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways, Denovo, Lundbeck, Relmada, Reviva, Rovi, Supernus, and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Kuleon Biosciences, LB Pharma, Mindpax, and Quantic. The other authors declare no competing interests. The authors alone are responsible for the content and writing of the paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board of the University of Hong Kong\/Hospital Authority Hong Kong West Cluster (UW 18-654). All methods adopted by the study were conducted in accordance with the Declaration of Helsinki. As the study was based on a health-record database, the requirement for informed consent was waived. There were no identifiable images from human research participants published in the study and thus no written informed consent for publication of the images would be required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}